[1]Watson JA,Watson CJ,McCrohan AM,et al.Generation of an epigenetic signature by chronic hypoxia in prostate cells.Hum Mol Genet.2009;18(19):3594-3604.[2]Perez-Perri JI,Dengler VL,Audetat KA,et al.The TIP60 complex is a conserved coactivator of HIF1A.Cell Rep. 2016; 1(16):37-47.[3]Wang Q,Zhang Y,Yang C,et al.Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux.Science.2010;327:1004-1007.[4]Chen Y,Zhang B,Bao L,et al.ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.J Clin Invest.2018;128(5):1937-1955.[5]Wu H,Kuo Y,Hung J,et al.K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression.Nat Commun. 2016;7:13644.[6]Luo W,Wang Y.Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity.Cell Mol Life Sci.2018;75(6):1043-1056.[7]Choudhry H,Harris AL.Advances in Hypoxia-Inducible Factor Biology.Cell Metab. 2018;27(2):281-298.[8]Fischer C,Leithner K,Wohlkoenig C,et al.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1alpha destabilization.Mol Cancer. 2015;14:4.[9]Lim JH,Lee YM,Chun YS,et al.Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.Mol Cell.2010;38(6):864-878.[10]Joo H,Yun M,Jeong J,et al.SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1α (HIF-1α) via direct interactions during hypoxia.Biochem Biophys Res Commun. 2015;462(4): 294-300.[11]Dioum EM,Chen R,Alexander MS,et al.Regulation of Hypoxia-Inducible Factor2 Signaling by the Stress-Responsive Deacetylase Sirtuin 1.Science. 2009;324 (5932):1289-1293.[12]Kang J,Chun Y,Huh J,et al.FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α.Redox Biol. 2018;19:364-374.[13]Furchert SE, Lanvers-Kaminsky C,Juürgens H,et al.Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood.Int J Cancer. 2007;120(8):1787-1794.[14]Decock A,Ongenaert M,Vandesompele J,et al. Neuroblastoma epigenetics: from candidate gene approaches to genome-wide screenings.Epigenetics.2011; 6(8):962-970.[15]Santini V,Gozzini A,Ferrari G.Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.Curr Drug Metab.2007;8(4):383-393.[16]Portela A,Esteller M.Epigenetic modifications and human disease.Nat Biotechnol. 2010;28(10):1057-1068.[17]Poljaková J,Groh T,Gudino ZO,et al.Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells.Oncol Rep. 2014;31(4):1928-1934.[18]Li Q,Costa M.c-Myc mediates a hypoxia-induced decrease in acetylated histone H4.Biochimie. 2009;91(10): 1307-1310.[19]Rardin MJ,Newman JC,Held JM,et al.Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways.Proc Natl Acad Sci U S A.2013;110(16):6601-6606.[20]Tseng AH,Wu LH,Shieh SS,et al.SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia.Biochem J. 2014;464(1):157-168.[21]Pellegrini L,Pucci B,Villanova L,et al.SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ. 2012;19(11):1815-1825. [22]Finley LWS,Haas W,Desquiret-Dumas V,et al.Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity.PloS One.2011;6(8):e23295.[23]Bell EL,Emerling BM,Ricoult SJ,et al.SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene. 2011;26(30): 2986-2996.[24]Dhillon RS,Richards JG.Hypoxia induces selective modifications to the acetylome in the brain of zebrafish (Danio rerio).Comp Biochem Physiol B Biochem Mol Biol. 2018;(224): 79-87.[25]Giralt A,Villarroya F.SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging.Biochem J. 2012; 444(1):1-10.[26]Qiao A,Wang K,Yuan Y,et al.Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia. Oncotarget.2016;28(7):43390-43400.[27]Liu P,Zou D,Chen K,et al. Dihydromyricetin Improves Hypobaric Hypoxia-Induced Memory Impairment via Modulation of SIRT3 Signaling.Mol Neurobiol. 2016;53(10): 7200-7212.[28]He W,Newman JC,Wang MZ,et al.Mitochondrial sirtuins: regulators of protein acylation and metabolism.Trends Endocrinol Metabol.2012;23(9):467-476.[29]Aquilano K,Vigilanza P,Baldelli S,et al.Peroxisome Proliferator-activated Receptor γ Co-activator 1α (PGC-1α) and Sirtuin 1 (SIRT1) Reside in Mitochondria.J Biol Chem. 2010;285(28):21590-21599.[30]Seligson DB,Horvath S,Shi T,et al.Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435(7046):1262-1266.[31]Watson JA,Watson CJ, McCrohan AM,et al.Generation of an epigenetic signature by chronic hypoxia in prostate cells.Hum Mol Genet.2009;18(19):3594-3604.[32]林瑞婷.柠檬酸裂酶的乙酰化调控及其在肺癌中的作用和分子机制[D].上海:复旦大学,2013.[33]李毓.乳腺癌细胞中CD74乙酰化调控的分子机制[D].上海:复旦大学,2017.[34]王文岩.肝癌细胞组蛋白H3乙酰化修饰定量及乙酰化分离富集新方法研究[D].上海:复旦大学,2011.[35]Giudice FS,Pinto DS Jr,Nör JE, et al.Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PloS One.2013;8(3):e58672.[36]Kaur J,Tikoo K.p300/CBP dependent hyperacetylation of histone potentiates anticancer activity of gefitinib nanoparticles.Biochim Biophys Acta. 2013;1833(5): 1028-1040.[37]Tariq M,Ito A,Ishfaq M,et al.Eukaryotic translation initiation factor 5A (eIF5A) is essential for HIF-1α activation in hypoxia. Biochem Biophys Res Commun. 2016;470(2):417-424.[38]Tang J,Zhuang S.Histone acetylation and DNA methylation in ischemia/reperfusion injury.Clin Sci.2019;133(4):597-609.[39]Bochaton T,Crola-Da-Silva C,Pillot B,et al.Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D.J Mol Cell Cardiol.2015;84:61-69.[40]Hafner AV,Dai J,Gomes AP,et al.Regulation of the mPTP by SIRT3‐mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging. 2012; 12(2):914-923. [41]Nadtochiy SM,Redman E,Rahman I,et al.Lysine deacetylation in ischaemic preconditioning: the role of SIRT1.Cardiovas Res.2011;89(3):643-649.[42]Nadtochiy SM,Urciuoli W,Zhang J,et al.Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.J Mol Cell Cardiol.2015;88:64-72.[43]Jia H,Guo Z,Yao Y.PDE5 inhibitor protects the mitochondrial function of hypoxic myocardial cells.Exp Ther Med. 2019; 17(1):199-204.[44]Sailhamer EA,Li Y,Smith EJ,et al.Hypoxic “second hit” in leukocytes from trauma patients: Modulation of the immune response by histone deacetylase inhibition. Cytokine. 2010; 49(3):303-311.[45]Srinivasan S,Chitalia V,Meyer RD,et al.Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Angiogenesis. 2015;18(4):449-462.[46]施华萍.低氧和HDAC抑制剂在心肌细胞对mir-126的协同诱导作用[D].杭州:浙江大学,2013.[47]李晨,陈迈,马恒.衰老心肌缺血/再灌注损伤增加的新机制—程序性坏死的关键作用[J].心脏杂志, 2016,29(3):263-267.[48]杨晓宇.组蛋白去乙酰化酶3(HDAC3)参与脑缺血预适应保护功能的机制研究[D].北京:中国科学院大学,2016.[49]Lu X,Deng Y,Yu D,et al.Histone Acetyltransferase p300 Mediates Histone Acetylation of PS1 and BACE1 in a Cellular Model of Alzheimer's Disease.PloS One. 2014;9(7): e103067.[50]Narayan PJ,Lill C,Faull R,et al.Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain. Neurobiol Dis.2015;74:281-294.[51]Frost B,Hemberg M,Lewis J,et al.Tau promotes neurodegeneration through global chromatin relaxation.Nat Neurosci.2014;17(3):357.[52]Leng Y, Wu Y, Lei S, et al.Inhibition of HDAC6 Activity Alleviates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Potential Role of Peroxiredoxin 1 Acetylation and Redox Regulation.Oxid Med Cell Longev. 2018;2018: 9494052. [53]Allfrey VG,Faul kner R,Mirsky AE.Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis.Proc Natl Acad Sci USA. 1964;51:786-794.[54]Yu BJ,Kim JA,Moon JH,et al.The diversity of lysineacetylated proteins in Escherichia coli.J Microbiol Biotechnol. 2008;18:1529-1536.[55]Goodman RH,Smolik S.CBP/P300 in cell growth, transformation and development.Genes Dev. 2000;14(13): 1553-1577.[56]Huai W,Liu X,Wang C,et al.KAT8 selectively inhibits antiviral immunity by acetylating IRF3. J Exp Med. 2019;216(4): 772-785. |